BioTricity Inc. Files 8-K on Financials
Ticker: BTCY · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1630113
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
BioTricity dropped an 8-K on Nov 14th financials - check it out.
AI Summary
BioTricity Inc. filed an 8-K on November 18, 2025, reporting on its Results of Operations and Financial Condition as of November 14, 2025. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This filing provides investors with updated financial information and operational results for BioTricity Inc., crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual events or significant risks.
Key Players & Entities
- BIOTRICITY INC. (company) — Registrant
- November 14, 2025 (date) — Date of earliest event reported
- November 18, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- Redwood City, California (location) — Principal Executive Offices
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated November 14, 2025.
What is the principal executive office address for BioTricity Inc.?
The principal executive office is located at 203 Redwood Shores Parkway, Suite 600, Redwood City, California 94065.
What is BioTricity Inc.'s SIC code and industry?
BioTricity Inc.'s SIC code is 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
What was the former name of BioTricity Inc.?
The former name of BioTricity Inc. was METASOLUTIONS, INC., with a date of name change on January 7, 2015.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-11-18 16:05:51
Filing Documents
- form8-k.htm (8-K) — 32KB
- ex99-1.htm (EX-99.1) — 25KB
- ex99-1_001.jpg (GRAPHIC) — 7KB
- 0001493152-25-024061.txt ( ) — 229KB
- btcy-20251114.xsd (EX-101.SCH) — 3KB
- btcy-20251114_lab.xml (EX-101.LAB) — 33KB
- btcy-20251114_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 18, 2025 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer